Impact of Oral Mesenchymal Stem Cells Applications as a Promising Therapeutic Target in the Therapy of Periodontal Disease

Int J Mol Sci. 2022 Nov 3;23(21):13419. doi: 10.3390/ijms232113419.

Abstract

Periodontal disease is a chronic inflammatory condition affecting about 20-50% of people, worldwide, and manifesting clinically through the detection of gingival inflammation, clinical attachment loss, radiographically assessed resorption of alveolar bone, gingival bleeding upon probing, teeth mobility and their potential loss at advanced stages. It is characterized by a multifactorial etiology, including an imbalance of the oral microbiota, mechanical stress and systemic diseases such as diabetes mellitus. The current standard treatments for periodontitis include eliminating the microbial pathogens and applying biomaterials to treat the bone defects. However, periodontal tissue regeneration via a process consistent with the natural tissue formation process has not yet been achieved. Developmental biology studies state that periodontal tissue is composed of neural crest-derived ectomesenchyme. The aim of this review is to discuss the clinical utility of stem cells in periodontal regeneration by reviewing the relevant literature that assesses the periodontal-regenerative potential of stem cells.

Keywords: bone healing; oral mesenchymal; periodontal ligament; periodontal regeneration; periodontitis; stem cells; target therapies.

Publication types

  • Review

MeSH terms

  • Alveolar Bone Loss*
  • Gingivitis*
  • Guided Tissue Regeneration, Periodontal
  • Humans
  • Mesenchymal Stem Cells*
  • Periodontal Diseases* / therapy
  • Periodontitis* / therapy